The abstract is read at the publisher; the summary is JClub's.
Co-internalizing anti-Ro52 with anti-MDA5 in primary human skeletal muscle myoblasts amplifies type I interferon transcription and type II interferon-inducible gene expression.
- Why it matters: Anti-Ro52 commonly co-occurs with myositis-specific autoantibodies like anti-MDA5, yet how these combinations shape interferon programs and disease risk is unclear.
- What they did: Primary myoblasts were electroporated with patient-derived IgG (anti-MDA5, anti-Mi-2, or anti-PM/Scl) plus anti-Ro52-positive IgG, then bulk RNA sequencing was performed 24 hours after internalization.
- The result: Anti-Ro52 potentiated anti-MDA5–driven IFNB1, ISG15, MX1, CXCL9, and CXCL10 across multiple antibody combinations and anti-Ro52 preparations, while anti-Ro52 reduced anti-Mi-2 and anti-PM/Scl–linked transcripts.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.